Hi,
Before most people notice a shift in the market, the signals usually appear in the data first.
Small surges in volume.
Order flow beginning to tilt.
Quiet movement across profiles that normally move under the radar.
These early indicators don’t always show up on major news feeds, but they’re exactly what experienced people monitor to understand where attention may move next.
During our latest market scan, the Stock News Trends research team identified three small-cap companies currently showing unusual early data signatures.
They’re not widely discussed yet.
But the underlying signals are starting to appear.
We’ve outlined the full breakdown inside our newest research brief.
Download the report here:
Access the Free Market Signal Guide
*By clicking the link above, you agree to be contacted by Stock News Trends via email
Often the biggest shifts begin quietly, long before they become obvious to the broader market.
Best,
Jeff Ackerman
Editor, Stock News Trends
*We encourage readers to perform their own research and due diligence on any information we provide.
Beyond the Magnificent 7: Part 2
Welcome back to our series on the biggest companies in the world outside the Mag 7.
In Part 1, we covered Saudi Aramco, TSMC, and Broadcom: the oil giant, the chipmaker, and the networking king.
Today, we're going even further down the list to the three companies sitting right behind them. These are all trillion-dollar (or near-trillion-dollar) businesses, and they couldn't be more different from each other.
Let's get into it.
Berkshire Hathaway (BRK.B)
Did you know that Warren Buffett isn't the CEO anymore?
You probably did, but we’ll tell you about it anyway.
He stepped down at the start of 2026. Greg Abel now runs the show. Buffett is still chairman at age 95, still in the office five days a week, and still making calls on investments, but in general, the keys have been handed over.
The company’s cash pile is historic. Berkshire is sitting on $373.31 billion in cash as of Dec 2025. Buffett spent 12 consecutive quarters selling stocks and stockpiling reserves leading up to that time, which many saw as a signal he thought the market was overpriced.
But Abel is making moves. He's resumed share buybacks for the first time since May 2024, committed to investing his entire 2026 salary into Berkshire stock, and closed a $9.7 billion acquisition of OxyChem.
Why it's cheap: The stock trades at about 15x earnings, well below its 10-year average of ~20x. The "Buffett premium" may be fading, but the business hasn't gotten worse. No dividend (hasn't paid one since 1967), but Abel hasn't ruled one out.
Walmart (WMT)
Walmart just became a $1 trillion company. And the reason isn't grocery aisles and greeters. It's because Walmart is quietly becoming a tech company.
The transformation. Fiscal year 2026 revenue: $713 billion. U.S. e-commerce grew 27% year-over-year in Q4, the 15th straight quarter of double-digit online growth. E-commerce now makes up 23% of total sales.
The real growth engine: advertising. Walmart Connect pulled in $6.4 billion in FY26, up 46% year-over-year. Digital ads are growing 6x faster than retail sales and carry much higher margins than selling groceries. This is the Amazon playbook, and Walmart is executing it.
The catch: The stock trades at roughly 45x trailing earnings. For a grocery company, that's insane. But the market is pricing in a high-margin advertising and e-commerce platform that happens to also sell bananas. It's a Dividend King (53 years of raises), too, but the yield is only ~0.8% because the stock has run up almost 13% YTD while the S&P 500 is down 4% (dividend shrinks when share price rises).
Eli Lilly (LLY)
If there's one company with a cheat code right now, it's Eli Lilly. The cheat code: tirzepatide. You know it as Mounjaro and Zepbound. Together, these two drugs did $36.5 billion in sales in 2025.
Foundayo just got approved. On April 1st, the FDA approved Lilly's oral GLP-1 pill. It's a once-daily pill with no food or water restrictions, unlike Novo Nordisk's competing Wegovy pill. Started shipping April 6th for as little as $25/month for eligible insured patients.
The pipeline goes deeper. Lilly has retatrutide in Phase 3, a triple-action drug showing an average of 71.2 lbs in weighloss for some patients, approaching surgical results. The GLP-1 market could reach $180 billion by 2035.
2026 guidance: $80-83 billion in revenue. That's 25% growth. Forward P/E is about 27x, which sounds high until you realize earnings are expected to grow 40%+ this year. The stock is actually down 13.40% YTD despite all the good news, which tells you expectations are sky-high.
Bottom Line
Three companies. Three completely different businesses. One thing in common: they're all in the top 15 most valuable companies on the planet.
Berkshire is the ultimate conglomerate entering uncharted territory with a new CEO and $333 billion in cash.
Walmart is proving the world's largest retailer can also become a high-margin advertising platform.
Eli Lilly is riding the biggest pharmaceutical wave in a generation, with a brand-new oral pill to boot.
Between this edition, Part 1, and the Mag 7 series, we've now covered the 13 biggest companies in the world. Let us know if you want us to keep going!
⭐️ What did you think of today's edition?
🫡 See You Next Week
That’s all for today’s special edition. We hope you got value from it. Reply and let us know if you did.
Until next week,
— Brandon & Blake
The information provided in Stocks & Income is for informational and educational purposes only and should not be construed as financial advice, investment advice, or a recommendation to buy or sell any securities. Stocks & Income is not a registered investment advisor, broker-dealer, or licensed financial planner. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We may hold positions in or receive compensation from the companies or products mentioned. Disclosures will be made where applicable.
Stocks & Income, AltIndex, Finance Wrapped, The Chain, and Future Funders are all owned by Invested, Inc.